Call Us

Q&A with Kelly O'Hare         

Navigating Cell Therapy Supply Chain Challenges

Insights from an Expert

With more than 30 years of experience in the biopharmaceutical industry, Kelly O'Hare shares valuable insights to help navigate cell therapy supply chain challenges.

Below are a few of the questions from the Q&A:

  • What are some of the biggest supply chain-related challenges facing companies manufacturing cell therapies?
  • What is needed to resolve these supply chain challenges?
  • What advice would you give to cell therapy manufacturers when they're thinking about these supply chain challenges, and where can they make the greatest inroads?
There's not one step that you can shortchange. It's a matter of building a robust and reliable network.

Kelly O'Hare

Senior Vice President of Operations, Lykan Bioscience

Submit Form Now to Download Q&A

Learn more about the supply chain challenges facing the cell therapy industry and expert perspective on how they can be resolved.

Don't miss this great opportunity to learn!

Form Title

Lykan Bioscience is committed to protecting and respecting your privacy. You can unsubscribe from email communications at any time. Please visit our Privacy Policy to learn more about your rights and how we use your information.

We are an innovative CDMO focused on cell-based therapies Partner Focused, Patient Driven


State-of-the-art, purpose-built, clinical and commercial manufacturing facility and process innovation/development laboratories


Organization that is committed to assessing and offering innovative processing and analytical platforms for cell therapy manufacturing


Decades of biotechnology industry experience focused on cell-based therapy and strong collaboration to enable operational excellence